tiprankstipranks
Appili Therapeutics Inc Class A (APLIF)
OTHER OTC:APLIF
US Market
APLIF
Appili Therapeutics Inc Class A
RESEARCH TOOLSreports

Appili Therapeutics Inc Class A (APLIF) Ratios

82 Followers

Appili Therapeutics Inc Class A Ratios

APLIF's free cash flow for Q1 2027 was C$0.99. For the 2027 fiscal year, APLIF's free cash flow was decreased by C$ and operating cash flow was C$-13.69. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 0.07 0.11 0.19 0.13 1.05
Quick Ratio
 0.07 0.11 0.19 0.13 1.05
Cash Ratio
 <0.01 <0.01 0.08 <0.01 0.83
Solvency Ratio
 -0.23 -0.22 -0.16 -0.30 -0.88
Operating Cash Flow Ratio
 -0.07 -0.07 0.06 -0.21 -3.39
Short-Term Operating Cash Flow Coverage
 -0.11 -0.11 0.08 -0.34 -89.26
Net Current Asset Value
C$ -19.03MC$ -17.34MC$ -13.42MC$ -10.95MC$ -7.41M
Leverage Ratios
Debt-to-Assets Ratio
 10.29 6.56 4.05 5.49 2.45
Debt-to-Equity Ratio
 -0.70 -0.75 -0.92 -0.75 -1.04
Debt-to-Capital Ratio
 -2.34 -2.94 -11.15 -2.99 28.56
Long-Term Debt-to-Capital Ratio
 -0.03 -0.04 -0.06 -0.09 48.65
Financial Leverage Ratio
 -0.07 -0.11 -0.23 -0.14 -0.42
Debt Service Coverage Ratio
 -0.43 -0.50 0.02 -0.24 -6.73
Interest Coverage Ratio
 -6.10 -6.45 -0.05 -1.33 -7.22
Debt to Market Cap
 10.07 6.97 2.90 1.93 1.68
Interest Debt Per Share
 0.11 0.11 0.13 0.08 0.08
Net Debt to EBITDA
 -2.25 -1.98 30.69 -3.91 -0.64
Profitability Margins
Gross Profit Margin
98.46%96.69%100.00%100.00%98.12%
EBIT Margin
-1547.35%-2675.64%345.58%-251.43%-2427.02%
EBITDA Margin
-1545.81%-2672.33%358.98%-249.78%-2425.14%
Operating Profit Margin
-1606.24%-2675.64%-190.00%-261.39%-2368.29%
Pretax Profit Margin
-1211.54%-1697.07%-2594.37%-448.55%-2755.01%
Net Profit Margin
-1236.07%-1736.73%-2613.12%-456.96%-2765.90%
Continuous Operations Profit Margin
-1236.07%-1736.73%-2613.12%-456.96%-2765.90%
Net Income Per EBT
102.02%102.34%100.72%101.87%100.40%
EBT Per EBIT
75.43%63.43%1365.48%171.60%116.33%
Return on Assets (ROA)
-361.50%-214.89%-86.55%-253.68%-295.08%
Return on Equity (ROE)
27.40%24.47%19.59%34.61%124.96%
Return on Capital Employed (ROCE)
33.10%39.22%1.51%21.52%-5098.06%
Return on Invested Capital (ROIC)
106.78%148.65%17.30%78.94%-2949.06%
Return on Tangible Assets
-361.50%-214.89%-86.55%-253.68%-295.08%
Earnings Yield
-353.74%-228.51%-61.84%-89.08%-203.18%
Efficiency Ratios
Receivables Turnover
 0.40 0.14 0.06 0.71 0.79
Payables Turnover
 <0.01 <0.01 <0.01 0.00 <0.01
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 39.43 22.28 5.27 27.45 22.87
Asset Turnover
 0.29 0.12 0.03 0.56 0.11
Working Capital Turnover Ratio
 -0.02 -0.02 >-0.01 -0.17 0.39
Cash Conversion Cycle
 -416.31K -273.95K -105.28K 517.60 -144.04K
Days of Sales Outstanding
 921.97 2.69K 6.07K 517.60 459.60
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 417.23K 276.65K 111.35K 0.00 144.50K
Operating Cycle
 921.97 2.69K 6.07K 517.60 459.60
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 -0.01 <0.01 -0.02 -0.09
Free Cash Flow Per Share
 >-0.01 -0.01 <0.01 -0.02 -0.09
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 0.97 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -36.63 -276.82K 368.14 -82.93 -3.18K
Capital Expenditure Coverage Ratio
 -36.63 -276.82K 368.14 -82.93 -3.18K
Operating Cash Flow Coverage Ratio
 -0.10 -0.11 0.07 -0.30 -1.32
Operating Cash Flow to Sales Ratio
 -3.58 -5.67 8.65 -2.98 -30.22
Free Cash Flow Yield
-99.53%-74.58%20.41%-58.76%-222.04%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.28 -0.44 -1.62 -1.12 -0.49
Price-to-Sales (P/S) Ratio
 3.49 7.60 42.26 5.13 13.61
Price-to-Book (P/B) Ratio
 -0.07 -0.11 -0.32 -0.39 -0.62
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.00 -1.34 4.90 -1.70 -0.45
Price-to-Operating Cash Flow Ratio
 -0.98 -1.34 4.89 -1.72 -0.45
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 0.05 0.02 <0.01
Price-to-Fair Value
 -0.07 -0.11 -0.32 -0.39 -0.62
Enterprise Value Multiple
 -2.48 -2.26 42.46 -5.97 -1.20
Enterprise Value
 14.51M 14.75M 15.31M 12.33M 9.75M
EV to EBITDA
 -2.48 -2.26 42.46 -5.97 -1.20
EV to Sales
 38.31 60.41 152.43 14.91 29.17
EV to Free Cash Flow
 -11.01 -10.66 17.67 -4.95 -0.97
EV to Operating Cash Flow
 -10.71 -10.66 17.62 -5.01 -0.97
Tangible Book Value Per Share
 -0.14 -0.14 -0.11 -0.09 -0.07
Shareholders’ Equity Per Share
 -0.14 -0.14 -0.11 -0.09 -0.07
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.02 >-0.01 -0.02 >-0.01
Revenue Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
 -0.04 -0.03 -0.02 -0.03 -0.08
Tax Burden
 1.02 1.02 1.01 1.02 1.00
Interest Burden
 0.78 0.63 -7.51 1.78 1.14
Research & Development to Revenue
 10.56 17.58 73.00 6.80 11.40
SG&A to Revenue
 6.49 10.15 28.41 3.68 13.28
Stock-Based Compensation to Revenue
 0.06 0.00 1.17 0.23 2.62
Income Quality
 0.29 0.33 -0.33 0.65 1.09
Currency in CAD